In the present study, patients with poor glycemic control were more likely to be prescribed a combination of OHAs and insulin, indicating the need for higher doses or additional treatment as an attempt to provide better glycemic control for the deteriorations of diabetes over time. The gene discussed is INS; the disease is diabetes mellitus.